Jacobs Engineering Group Inc.
(NYSE:JEC) announced today that it was awarded a contract from
to provide detail engineering services for the expansion and refurbishment of its Flu Vaccine Facility in Ocoyoacac, Mexico.
Officials did not disclose the contract value, but noted that this is the second phase of the Aguila Project; the first phase was executed in 2010 by Jacobs’ offices in Lyon, France and Mexico City, Mexico. Jacobs is executing this detail engineering phase of the project from its Mexico operations. The overall goal of the project is to increase plant production capacity.
In making the announcement, Jacobs Group Vice President Mike Autrey stated, “We are committed to a long term relationship with Sanofi and we are very pleased to be part of this plant production expansion project. We look forward to continuing to deliver value and technical excellence to Sanofi.”
Jacobs is one of the world's largest and most diverse providers of technical, professional, and construction services.
Statements made in this release that are not based on historical fact are forward-looking statements. We base these forward-looking statements on management’s current estimates and expectations as well as currently available competitive, financial and economic data. Forward-looking statements, however, are inherently uncertain. There are a variety of factors that could cause business results to differ materially from our forward-looking statements. For a description of some of the factors which may occur that could cause actual results to differ from our forward-looking statements please refer to our 2012 Form 10-K, and in particular the discussions contained under Items 1 - Business, 1A - Risk Factors, 3 - Legal Proceedings, and 7 - Management's Discussion and Analysis of Financial Condition and Results of Operations. We do not undertake to update any forward-looking statements made herein.